Nordic healthcare and biotech growth capital investor KDev Investments, jointly owned by Karolinska Development and Rosetta Capital, has sold its stake in Swedish pharmaceutical research business Inhalation Sciences to Råsunda Förvaltning.
Other investors in the deal include venture capital firms NextStage and Mi3 Venture Partners
Corporate services provider Equiom was bought by LDC in a 2013 secondary buyout
Corialis has expanded its workforce by more than 40% under the ownership of Advent
Telecommunications support business will look to undertake a geographic expansion strategy